Cargando…

Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis

Detalles Bibliográficos
Autores principales:	Zhang, Shengzhe, Lee, Sung Ho, Nie, Litong, Huang, Yuanjian, Zou, Gengyi, Jung, Youn‐Sang, Jun, Sohee, Zhang, Jie, Lien, Esther M., Chen, Junjie, Park, Jae‐Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859727/ https://www.ncbi.nlm.nih.gov/pubmed/36336962 http://dx.doi.org/10.1002/cac2.12382

Ejemplares similares

LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling
por: Scheffler, Julia M., et al.
Publicado: (2014)

The metabolic regulator Lamtor5 suppresses inflammatory signaling via regulating mTOR-mediated TLR4 degradation
por: Zhang, Wei, et al.
Publicado: (2019)

CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion
por: Zou, Gengyi, et al.
Publicado: (2023)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation
por: Xu, Jichuan, et al.
Publicado: (2023)

CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma
por: Kim, Bongjun, et al.
Publicado: (2023)

CRACD loss promotes small cell lung cancer tumorigenesis via EZH2-mediated immune evasion
por: Zhang, Shengzhe, et al.
Publicado: (2023)

LAMTOR1 depletion induces p53-dependent apoptosis via aberrant lysosomal activation
por: Malek, M, et al.
Publicado: (2012)

The mTOR–lysosome axis at the centre of ageing
por: Carosi, Julian M., et al.
Publicado: (2021)

mTORC1 Signaling Is Palmitoylation-Dependent in Hippocampal Neurons and Non-neuronal Cells and Involves Dynamic Palmitoylation of LAMTOR1 and mTOR
por: Sanders, Shaun S., et al.
Publicado: (2019)

LAMTOR1 inhibition of TRPML1‐dependent lysosomal calcium release regulates dendritic lysosome trafficking and hippocampal neuronal function
por: Sun, Jiandong, et al.
Publicado: (2022)

Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk
por: De Araujo, Mariana E., et al.
Publicado: (2013)

Autophagy termination and lysosome reformation regulated by mTOR
por: Yu, Li, et al.
Publicado: (2010)

Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
por: Wang, Andrew, et al.
Publicado: (2017)

Brucea javanica Oil Emulsion Promotes Autophagy in Ovarian Cancer Cells Through the miR-8485/LAMTOR3/mTOR/ATG13 Signaling Axis
por: Wang, Yihan, et al.
Publicado: (2022)

Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer
por: Ko, Kyung-Pil, et al.
Publicado: (2023)

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
por: Settembre, Carmine, et al.
Publicado: (2012)

Rapamycin directly activates lysosomal mucolipin TRP channels independent of mTOR
por: Zhang, Xiaoli, et al.
Publicado: (2019)

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
por: Yuan, RuiRong, et al.
Publicado: (2009)

mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells
por: Saric, Amra, et al.
Publicado: (2016)

Ubiquilins Regulate Autophagic Flux through mTOR Signaling and Lysosomal Acidification
por: Şentürk, Mümine, et al.
Publicado: (2019)

Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma
por: Gan, Ning, et al.
Publicado: (2017)

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer
por: Kang, Chifei, et al.
Publicado: (2021)

The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget’s disease
por: Song, Yongli, et al.
Publicado: (2020)

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
por: Li, Xiaoyan, et al.
Publicado: (2014)

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors
por: Clegg, Nicola J., et al.
Publicado: (2011)

Th-POK regulates mammary gland lactation through mTOR-SREBP pathway
por: Zhang, Rui, et al.
Publicado: (2018)

Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2012)

The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation
por: Hartwig, Pia, et al.
Publicado: (2021)

Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer
por: De Santis, Maria Chiara, et al.
Publicado: (2023)

Alt-RPL36 downregulates the PI3K-AKT-mTOR signaling pathway by interacting with TMEM24
por: Cao, Xiongwen, et al.
Publicado: (2021)

Functional characterization of the lysosomal membrane protein TMEM192 in mice
por: Nguyen, Thuy Linh, et al.
Publicado: (2017)

Gating and selectivity mechanisms for the lysosomal K(+) channel TMEM175
por: Oh, SeCheol, et al.
Publicado: (2020)

Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175
por: Oh, SeCheol, et al.
Publicado: (2022)

LAMTOR/Ragulator regulates lipid metabolism in macrophages and foam cell differentiation
por: Lamberti, Giorgia, et al.
Publicado: (2019)

LAMTOR1 degrades MHC-II via the endocytic in hepatocellular carcinoma
por: Wu, Bo, et al.
Publicado: (2022)

TMEM139 prevents NSCLC metastasis by inhibiting lysosomal degradation of E‐cadherin
por: Zhang, Shuai, et al.
Publicado: (2022)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013)

Correction: Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6bjvng4niirj5m3pfvusvqtpju